z-logo
open-access-imgOpen Access
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines Against Symptomatic SARS-CoV-2 Infection and Severe COVID-19 Outcomes in Ontario, Canada
Author(s) -
Hannah Chung,
Siyi He,
Sharifa Nasreen,
Maria E. Sundaram,
Sarah A. Buchan,
Sarah Wilson,
Branson Chen,
Andrew Calzavara,
Deshayne B. Fell,
Peter C. Austin,
Kumanan Wilson,
Kevin L. Schwartz,
Kevin A. Brown,
Jonathan B. Gubbay,
Nicole E. Basta,
Salaheddin M. Mahmud,
Christiaan H. Righolt,
Lawrence W. Svenson,
Shan E. MacDonald,
Naveed Z. Janjua,
Mina Tadrous,
Jeffrey C. Kwong,
Canadian Immunization Research Network Provincial Collaborative Network Investigators Group
Publication year - 2021
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.3845993
Subject(s) - covid-19 , medicine , virology , intensive care medicine , outbreak , infectious disease (medical specialty) , disease

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom